New York Health Stock Analysis

BBAL Stock  USD 0.0001  0.00  0.00%   
Below is the normalized historical share price chart for New York Health extending back to January 03, 2003. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of New York stands at 0.0001, as last reported on the 3rd of March, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day.
IPO Date
20th of December 1996
200 Day MA
0.0001
50 Day MA
0.0001
Beta
(12.75)
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
At this time, New York's Short and Long Term Debt is quite stable compared to the past year. Long Term Debt To Capitalization is expected to rise to 0.03 this year, although the value of Net Debt To EBITDA will most likely fall to 2.41. New York's financial risk is the risk to New York stockholders that is caused by an increase in debt.
 
Debt Ratio  
First Reported
2010-12-31
Previous Quarter
0.003997
Current Value
0.003797
Quarterly Volatility
0.00050759
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Total Stockholder Equity is expected to rise to about (2.4 M) this year. The value of Treasury Stock is estimated to slide to about (11.1 K). Price Earnings To Growth Ratio is expected to rise to 0.03 this year, although the value of Price To Sales Ratio will most likely fall to 0.05.
New York Health is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of New York stock analysis is to determine its intrinsic value, which is an estimate of what New York Health is worth, separate from its market price. There are two main types of New York's stock analysis: fundamental analysis and technical analysis.
The New York stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in New York Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

New Stock Analysis Notes

The company had not issued any dividends in recent years. New York Health had 1:1.5 split on the 3rd of January 2003. New York Health Care, Inc. operates as a home care services agency primarily in New York. The company was founded in 1983 and is based in Valley Stream, New York. New York operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 1460 people. For more info on New York Health please contact the company at 718-375-6700 or go to https://www.nyhc.com.

New York Quarterly Total Revenue

10.59 Million

New York Health Investment Alerts

New York Health generated a negative expected return over the last 90 days
New York Health has some characteristics of a very speculative penny stock
New York Health currently holds 25.64 K in liabilities. New York Health has a current ratio of 0.75, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about New York's use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 44.4 M. Net Loss for the year was (1.05 M) with profit before overhead, payroll, taxes, and interest of 7.35 M.
New York Health currently holds about 5.37 M in cash with (88.61 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
New York Health has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Hims Hers GLP-1 pill gambit backfires, accelerating crackdown on drug compounders - Reuters

New Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 335.33 K.

New Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.11)(0.12)
Return On Capital Employed(0.39)(0.37)
Return On Assets(0.10)(0.10)
Return On Equity 0.43  0.45 

Management Efficiency

New York Health has return on total asset (ROA) of 0.0364 % which means that it generated a profit of $0.0364 on every $100 spent on assets. This is way below average. New York's management efficiency ratios could be used to measure how well New York manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is expected to rise to 0.45 this year, although the value of Return On Tangible Assets will most likely fall to (0.12). At this time, New York's Total Assets are quite stable compared to the past year. Other Current Assets is expected to rise to about 156.3 K this year, although the value of Intangible Assets will most likely fall to about 537 K.
Last ReportedProjected for Next Year
Book Value Per Share(0.10)(0.09)
Tangible Book Value Per Share(0.15)(0.14)
Enterprise Value Over EBITDA 0.57  0.54 
Price Book Value Ratio(0.59)(0.56)
Enterprise Value Multiple 0.57  0.54 
Price Fair Value(0.59)(0.56)
Enterprise Value-462 K-438.9 K
Evaluating the management effectiveness of New York allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The New Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Operating Margin
(0.02)
Profit Margin
0.0048
Beta
(12.75)
Return On Assets
0.0364

Technical Drivers

New York Health technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.

New York Health Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Double Exponential Moving Average indicator was developed by Patrick Mulloy. It consists of a single exponential moving average and a double exponential moving average. This indicator is more responsive to New York Health changes than the simple moving average.

New York Outstanding Bonds

New York issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. New York Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most New bonds can be classified according to their maturity, which is the date when New York Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

New York Bond Ratings

New York Health financial ratings play a critical role in determining how much New York have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for New York's borrowing costs.
Piotroski F Score
2
FrailView
Beneish M Score
(2.34)
Unlikely ManipulatorView

New York Health Debt to Cash Allocation

Many companies such as New York, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
New York Health currently holds 25.64 K in liabilities. New York Health has a current ratio of 0.75, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about New York's use of debt, we should always consider it together with its cash and equity.

New York Total Assets Over Time

New York Assets Financed by Debt

The debt-to-assets ratio shows the degree to which New York uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

New York Debt Ratio

    
  0.38   
It seems most of the New York's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the New York's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of New York, which in turn will lower the firm's financial flexibility.

New York Corporate Bonds Issued

About New Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how New York prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling New shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as New York. By using and applying New Stock analysis, traders can create a robust methodology for identifying New entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.03)(0.03)
Operating Profit Margin 0.02  0.02 
Net Loss(0.03)(0.03)
Gross Profit Margin 0.20  0.26 

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding New York to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run ETFs Now

   

ETFs

Find actively traded Exchange Traded Funds (ETF) from around the world
All  Next Launch Module
When determining whether New York Health is a strong investment it is important to analyze New York's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact New York's future performance. For an informed investment choice regarding New Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in New York Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of New York. Projected growth potential of New fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive New York assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Revenue Per Share
1.365
Quarterly Revenue Growth
(0.02)
Return On Assets
0.0364
The market value of New York Health is measured differently than its book value, which is the value of New that is recorded on the company's balance sheet. Investors also form their own opinion of New York's value that differs from its market value or its book value, called intrinsic value, which is New York's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because New York's market value can be influenced by many factors that don't directly affect New York's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between New York's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding New York should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, New York's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.